Compare · MAIN vs SFE
MAIN vs SFE
Side-by-side comparison of Main Street Capital Corporation (MAIN) and Safeguard Scientifics Inc. (SFE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MAIN and SFE operate in Finance/Investors Services (Finance), so they compete in similar markets.
- MAIN is the larger of the two at $5.47B, about 53.9x SFE ($101.5M).
- MAIN has hit the wire 20 times in the past 4 weeks while SFE has been quiet.
- MAIN has more recent analyst coverage (12 ratings vs 0 for SFE).
Main Street Capital Corporation
Main Street Capital Corporation is a private equity firm specializes in equity capital to lower middle market companies. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides "one stop" financing alternatives within its lower middle market portfolio. The firm typically invests in lower middle market companies generally with annual revenues between $10 million and $150 million. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It makes majority and minority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas.
Safeguard Scientifics Inc.
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
Latest MAIN
- EVP AND COO Morris Jesse E sold $2,049,250 worth of shares (35,000 units at $58.55), decreasing direct ownership by 13% to 232,568 units (SEC Form 4)
- Main Street Announces New Portfolio Investment
- Director Foster Vincent D acquired $253,014 worth of shares (4,867 units at $51.98), increasing direct ownership by 0.22% to 1,676,609 units (SEC Form 4)
- CEO, SMD Hyzak Dwayne L. acquired $74,187 worth of shares (1,427 units at $51.98), increasing direct ownership by 0.28% to 508,275 units (SEC Form 4)
- PRESIDENT, CIO AND SMD Magdol David L. acquired $17,553 worth of shares (335 units at $52.35), increasing direct ownership by 0.08% to 441,023 units (SEC Form 4)
- EVP, GC, SECRETARY Beauvais Jason B acquired $17,932 worth of shares (345 units at $51.98), increasing direct ownership by 0.18% to 196,530 units (SEC Form 4)
- Director Lane Brian E. acquired $42,907 worth of shares (825 units at $52.04), increasing direct ownership by 2% to 53,086 units (SEC Form 4)
- Director Griffin Jon Kevin acquired $45,564 worth of shares (875 units at $52.05), increasing direct ownership by 1% to 74,663 units (SEC Form 4)
- Director Jackson John Earl acquired $57,919 worth of shares (1,113 units at $52.05), increasing direct ownership by 1% to 85,495 units (SEC Form 4)
- Director Solcher Stephen B acquired $33,643 worth of shares (646 units at $52.06), increasing direct ownership by 1% to 52,628 units (SEC Form 4)
Latest SFE
- SEC Form 15-12G filed by Safeguard Scientifics Inc.
- SEC Form SC 13E3/A filed by Safeguard Scientifics Inc. (Amendment)
- SEC Form EFFECT filed by Safeguard Scientifics Inc.
- SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)
- SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)
- SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)
- Safeguard Scientifics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form POS AM filed by Safeguard Scientifics Inc.
- SEC Form S-8 POS filed by Safeguard Scientifics Inc.
- SEC Form S-8 POS filed by Safeguard Scientifics Inc.